Most of Wall Street rises, but sinking AI stocks send it lower for the week
NEW YORK (AP) — Most of the U.S. stock market rose Friday after oil prices eased back to…
FuturHealth expands digital health platform to boost convenience for oral GLP-1 drugs
Clinical guidance health platform FuturHealth has expanded its oral GLP-1 receptor agonist options with orforglipron — branded Foundayo…
Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Eli Lilly is spending $3.25 billion to acquire Kelonia Therapeutics, a small biotech company developing cell therapies for…
Ozempic Goes Generic —But Not in the US
A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…
S&P upgrades Ireland to within a notch of triple-A for first time since 2009 – The Irish Times
S&P Global, one of the world’s largest credit ratings agencies, has upgraded its view of Ireland’s creditworthiness to…
US stocks lose ground as war with Iran keeps pressure on oil prices
Stock indexes on Wall Street are losing ground in afternoon trading Friday, as the fallout from the war…
Why haven’t Trump’s tariffs caused a downturn in the US? – The Irish Times
When Donald Trump famously announced his Liberation Day tariff assault on the world last April, economists, almost en…
Gabriel Makhlouf sticks to ECB line on rates as US tariffs help keep inflation anchored – The Irish Times
After months of rollercoaster uncertainty, the euro zone, at the end of last year, settled into a strange…
In a trade war between the EU and the US, what happens to a city like Galway? – The Irish Times
The one thing that successive Irish governments want to avoid is having to make a choice between Europe…
Lilly in talks to buy Ventyx Biosciences for more than $1 billion, WSJ reports
Jan 6 (Reuters) – Eli Lilly is in advanced talks to buy Ventyx Biosciences for more than $1…
Ireland dodged a bullet this year. But there’s a caveat – The Irish Times
The Irish economy dodged a bullet this year. Several of them, in fact. Back in April, we were…
Lilly, Novo to Lower Obesity Drug Prices in Trump Deal
(Bloomberg) — Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash…